HRTX
Heron Therapeutics·NASDAQ
--
--(--)
--
--(--)
4.75 / 10
Netural
Heron Therapeutics has modest fundamental strength with an interest coverage ratio of 15.48 and positive revenue growth of 10.45% YoY. However, a high days sales outstanding of 188.86 suggests slow receivable collection. Net income is positive but below peers on a per-revenue basis. Overall, the company is rated neutral with selective investment appeal.
Analysis Checks(9/10)
Revenue-MV
Value0.11
Score3/3
Weight19.66%
1M Return10.54%
Value0.11
Score3/3
Weight19.66%
1M Return10.54%
Days sales outstanding
Value188.86
Score0/3
Weight-6.94%
1M Return-5.18%
Value188.86
Score0/3
Weight-6.94%
1M Return-5.18%
Net income-Revenue
Value-0.17
Score2/3
Weight15.69%
1M Return8.45%
Value-0.17
Score2/3
Weight15.69%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.57%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.57%
1M Return-1.11%
Asset-MV
Value-0.50
Score2/3
Weight20.21%
1M Return10.15%
Value-0.50
Score2/3
Weight20.21%
1M Return10.15%
Total operating revenue (YoY growth rate %)
Value10.45
Score2/3
Weight1.68%
1M Return1.11%
Value10.45
Score2/3
Weight1.68%
1M Return1.11%
Profit-MV
Value0.46
Score2/3
Weight15.67%
1M Return8.45%
Value0.46
Score2/3
Weight15.67%
1M Return8.45%
PB-ROE
Value-0.28
Score2/3
Weight19.55%
1M Return9.14%
Value-0.28
Score2/3
Weight19.55%
1M Return9.14%
Operating revenue (YoY growth rate %)
Value10.45
Score2/3
Weight0.65%
1M Return0.43%
Value10.45
Score2/3
Weight0.65%
1M Return0.43%
Cash-MV
Value-1.82
Score2/3
Weight15.41%
1M Return8.41%
Value-1.82
Score2/3
Weight15.41%
1M Return8.41%
Revenue-MV
Value0.11
Score3/3
Weight19.66%
1M Return10.54%
Value0.11
Score3/3
Weight19.66%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value10.45
Score2/3
Weight1.68%
1M Return1.11%
Value10.45
Score2/3
Weight1.68%
1M Return1.11%
Days sales outstanding
Value188.86
Score0/3
Weight-6.94%
1M Return-5.18%
Value188.86
Score0/3
Weight-6.94%
1M Return-5.18%
Profit-MV
Value0.46
Score2/3
Weight15.67%
1M Return8.45%
Value0.46
Score2/3
Weight15.67%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight15.69%
1M Return8.45%
Value-0.17
Score2/3
Weight15.69%
1M Return8.45%
PB-ROE
Value-0.28
Score2/3
Weight19.55%
1M Return9.14%
Value-0.28
Score2/3
Weight19.55%
1M Return9.14%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.57%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.57%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value10.45
Score2/3
Weight0.65%
1M Return0.43%
Value10.45
Score2/3
Weight0.65%
1M Return0.43%
Asset-MV
Value-0.50
Score2/3
Weight20.21%
1M Return10.15%
Value-0.50
Score2/3
Weight20.21%
1M Return10.15%
Cash-MV
Value-1.82
Score2/3
Weight15.41%
1M Return8.41%
Value-1.82
Score2/3
Weight15.41%
1M Return8.41%
Is HRTX fundamentally strong?
- HRTX scores 4.75/10 on fundamentals and holds a Fair valuation at present. Backed by its 0.00% ROE, -8.75% net margin, -17.02 P/E ratio, 15.52 P/B ratio, and 43.75% earnings growth, these metrics solidify its Netural investment rating.
